.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Colorcon
UBS
Fish and Richardson
Mallinckrodt
Daiichi Sankyo
Medtronic
Julphar
Boehringer Ingelheim
Healthtrust

Generated: July 26, 2017

DrugPatentWatch Database Preview

LUVERIS Drug Profile

« Back to Dashboard

Which patents cover Luveris, and when can generic versions of Luveris launch?

Luveris is a drug marketed by Emd Serono and is included in one NDA.

The generic ingredient in LUVERIS is lutropin alfa. Additional details are available on the lutropin alfa profile page.

Summary for Tradename: LUVERIS

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list20
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LUVERIS at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emd Serono
LUVERIS
lutropin alfa
INJECTABLE;SUBCUTANEOUS021322-001Oct 8, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LUVERIS

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Emd Serono
LUVERIS
lutropin alfa
INJECTABLE;SUBCUTANEOUS021322-001Oct 8, 2004► Subscribe► Subscribe
Emd Serono
LUVERIS
lutropin alfa
INJECTABLE;SUBCUTANEOUS021322-001Oct 8, 2004► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Moodys
Novartis
Argus Health
US Army
AstraZeneca
Accenture
Baxter
Harvard Business School
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot